Author:
Bedi Mannat,Kieft Aria,Joiner Michael,Miller Steven
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. A review of cervical cancer: incidence and disparities;Buskwofie A;J Natl Med Assoc,2020
2. U.S. Cancer Statistics Working Group. U.S. cancer statistics data visualizations tool, based on 2022 submission data (1999-2020). U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. (2022). https.//www.cdc.gov/cancer/dataviz.
3. Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology;Collins Y;Gynecol Oncol,2014
4. Are older patients with cervical cancer managed differently to younger patients? An international survey;Frelaut M;Cancers (Basel),2019
5. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial;Lorusso D;Lancet,2024